u/first_hundred

FLOW was kidney outcomes and it is the one nobody quotes

The system suitability argument, since it comes up whenever somebody posts a number without one.

Before the sample result means anything, the instrument has to be shown to be fit that day: replicate injections with an acceptable RSD on area, a tailing factor inside limits, adequate plate count, and a resolution check between the pair you care about.

None of that is exotic and all of it is routine in a laboratory that reports for a living. Its absence does not mean a number is wrong; it means the number is unanchored, and unanchored numbers should not be quoted to two decimal places on this board.

Agreed, and it is why GL Biochem printing the column and gradient on the certificate is genuinely useful rather than decorative.

This is the whole methodological point of the board in one line.

Correction: that is a tailing factor, not a plate count. Different diagnostics for different problems.

a shoulder is not an impurity until you can resolve it

Same view. BCH prints the column and the gradient, which means somebody could actually reproduce the run.

Did you ask for the batch-specific document, or is this the catalogue one?

a non-peptide agonist does not degrade the way a peptide does

Left up and flaired Explainer. This is the answer we keep linking, written properly.

a mean is not a promise

Same view — reporting the gradient is what makes a result checkable rather than merely stated.

the confidence interval is the finding, the point estimate is the headline

Gave the same trace to two people I trust and got two integrations about a point apart. That was the most educational afternoon I have had here.

Area percent is the integrated area of your peak over the total integrated area at one wavelength on one gradient. Change any of those and the number changes without the sample changing.

Same view. SWB prints the column and the gradient, which means somebody could actually reproduce the run.

Correction: that is a tailing factor, not a plate count. Different diagnostics for different problems.

Correcting myself upthread: I said the gradient was linear and looking again it has a hold in the middle.

Retention time shifted 0.4 minutes and I assumed the worst. It was the column temperature.

Why two honest labs report different numbers on the same vial.

Disagreeing with this bit: that spread is ordinary inter-lab variance, not a disagreement about the material.

Reminder: a question about a document is not an accusation about a supplier, and posts that blur the two get retitled.

Read a press release and the publication three months apart. The hedging in the second one was substantial.

Open-label extensions lose their randomisation. Anybody still enrolled at week 104 is a selected group and the numbers describe that group.

Yes. Retention time is a hypothesis about identity. Mass is the answer.

Reminder: a question about a document is not an accusation about a supplier, and posts that blur the two get retitled.

Left up and flaired Explainer. This is the answer we keep linking, written properly.

Left up and flaired Explainer. This is the answer we keep linking, written properly.

Same view — reporting the gradient is what makes a result checkable rather than merely stated.

The registered protocol is public. Comparing the registered primary endpoint with the reported one is a two-minute check and it is how outcome switching gets caught.

Agreed, and it is why KP printing the column and gradient on the certificate is genuinely useful rather than decorative.

That is the 68-week readout, not the 72-week one. Different trial, different duration.

Ran a blank after a high-concentration injection and found the carryover I had been calling an impurity.

Correction: that is net peptide content, not purity. Different number, different meaning, and the document says so if you read the row label.

How to ask for a batch record without it turning into a negotiation.

Adding the bit that always gets missed: the lot on the vial has to match the lot on the page, or none of this applies to your material.

That is the 68-week readout, not the 72-week one. Different trial, different duration.

Can you post the trace with the axes labelled?

What wavelength, and what was the gradient?

Reminder: a question about a document is not an accusation about a supplier, and posts that blur the two get retitled.

How to read one of these papers in fifteen minutes, in the order that actually helps.

Start with the registered protocol and check the primary endpoint against what is reported. Then the methods: who was included, what the comparator was, how long the randomised phase ran. Then the discontinuation numbers, which are a tolerability result and are usually in a supplementary table.

Only then the efficacy figure, and read the interval rather than the point estimate. Finish with the limitations section, which is where the authors say what they actually think.

Fifteen minutes, and you will know more than any thread summarising it.

Batch number and date of analysis, are both on there?

Did you get the chromatogram or only the summary line?